Revisiting GM-CSF as an adjuvant for therapeutic vaccines

Cell Mol Immunol. 2018 Feb;15(2):187-189. doi: 10.1038/cmi.2017.105. Epub 2017 Oct 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology*
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / immunology
  • Humans
  • Immune Tolerance / drug effects
  • Immunity / drug effects
  • Mice
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Vaccines / immunology*

Substances

  • Adjuvants, Immunologic
  • Vaccines
  • Granulocyte-Macrophage Colony-Stimulating Factor